Database on global MDR-TB research activities
Background
Currently, there is a lack of evidence available to develop policy recommendations for the management of multidrug-resistant tuberculosis (MDR-TB) in low- and middle-income settings. As a result, WHO and partners developed the DOTS-Plus strategy which is currently being tested through pilot projects and operational research activities. In order to stimulate global MDR-TB research activities the Stop TB Working Group on DOTS-Plus for MDR-TB has developed a prioritised research agenda for DOTS-Plus.
-
A prioritised research agenda for DOTS-Plus
pdf, 52kb
A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB). The Stop TB Working Group on DOTS-Plus for MDR-TB. International Journal of Tuberculosis and Lung Disease 2003, 7(5): 410-414.
In addition, a database on global MDR-TB research activities has been created with the following purposes:
- To match this catalogue of ongoing research activities with the established research agenda for DOTS-Plus to ensure all topics needed to develop policy of DOTS-Plus are covered and to stimulate research activities in areas not covered.
- To create a global network whereby collaboration across institutions interested in the same area could be pursued with the intent of jointly addressing research activities.
Currently this database contains more than 70 MDR-TB research projects in 26 countries. Should you wish to include your project into this database, please fill in the online questionnaire.
To search for projects in the MDR-TB research database, please select either a research category or a country and click "Search".
Search by Research Category
Search by Country
The information displayed is solely the responsibility of the investigators and not of WHO. The link to the article: A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB), is posted with permission from The International Journal of Tuberculosis and Lung Disease.
